Skip to main content
Log in

Comparison of subacute effects of oxazacort and prednisone on mineral metabolism in man

  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Summary

Prolonged therapeutic administration of prednisone or other corticosteroids frequently produces severe osteopenia with an increased incidence of bone fractures. Recent efforts to decrease the severity of corticosteroid-induced osteopenia have included the development of corticosteroid analogues designed to possess diminished bone-wasting effects relative to their anti-inflammatory activity. We compared the effects of an oxazoline derivative of prednisolone, oxazacort (azacortinol), with those of prednisone on mineral metabolism in man. After a 12-day equilibration period on a 600 mg/day calcium diet, normal volunteers were studied for 15 days during treatment with either prednisone (20 mg/day, 12 subjects) or oxazacort (25 mg/day, 10 subjects). There was no difference between the two groups with regard to the effects of each corticosteroid on serum ionized calcium, phosphate, alkaline phosphatase, immunoreactive parathyroid hormone (iPTH), and 25-hydroxyvitamin D (25OHD) concentrations. Both corticosteroids suppressed intestinal47Ca absorption to a similar degree after 15 days of treatment (prednisone: −28.5±7.5, oxazacort: −30.2±4.4% of initial values). Although both corticosteroids increased 24-h urinary calcium excretion significantly above pretreatment values, this effect was less marked in the oxazacort-treated subjects. The mean cumulative 15-day increase in urinary calcium excretion in the prednisone-treated group (+326 ± 54 mg/g creatinine/24 h) was more than twice as great as that in the oxazacort-treated group (+146 ± 48 mg/g creatinine/24 h), a difference significant atP<0.001. It is concluded that the increase in urinary calcium excretion, and presumably the negative calcium balance, produced by a 2-week administration of oxazacort is significantly less pronounced than that produced by an equivalent dose of prednisone.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Miravet, L., Hioco, D., Debeyre, N., Dryll, A., Ryckewaert, A., de Seze, S.: La cinétique du calcium au cours de l'ostéoporose cortisonique. Effet d'un anabolisant de synthése, Sem. Hop. Paris [Suppl.]42:60–64, 1966

    Google Scholar 

  2. Wajchenberg, B.L., Pereira, V.G., Kieffer, J., Ursic, S.: Effect of dexamethasone on calcium metabolism and47Ca kinetics in normal subjects, Acta Endocrinol. (Kbh.)61:173–192, 1969

    CAS  Google Scholar 

  3. Gallagher, J.C., Aaron, J., Horsman, A., Wilkinson, R., Nordin, B.E.C.: Corticosteroid osteoporosis, Clin. Endocrinol. Metab.2:355–368, 1973

    Article  PubMed  CAS  Google Scholar 

  4. Teotia, M., Teotia, S.P.S., Raman, T., Sharma, N.L., Singh, R.K.: Intestinal absorption of calcium and phosphorus: experiments on interaction between vitamin D and adrenocortical hormone, Indian J. Pediatr.42:1–9, 1975

    PubMed  CAS  Google Scholar 

  5. Lukert, B.P., Adams, J.S.: Calcium and phosphorus homeostasis in man: effect of corticosteroids, Arch. Intern. Med.136:1249–1253, 1976

    Article  PubMed  CAS  Google Scholar 

  6. Klein, R.G., Arnaud, S.B., Gallagher, J.C., DeLuca, H.F., Riggs, B.L.: Intestinal calcium absorption in exogenous hypercortisolism: role of 25-hydroxy-vitamin D and corticosteroid dose, J. Clin. Invest.60:253–259, 1977

    PubMed  CAS  Google Scholar 

  7. Hahn, T.J., Halstead, L.R., Teitelbaum, S.L., Hahn, B.H.: Altered mineral metabolism in glucocorticoid-induced osteopenia: effect of 25-hydroxyvitamin D administration, J. Clin. Invest.64:655–665, 1979

    PubMed  CAS  Google Scholar 

  8. Curtiss, P.H., Clark, W.S., Herndon, C.H.: Vertebral fractures resulting from prolonged cortisone and corticotrophin therapy, J.A.M.A.156:467–469, 1954

    Google Scholar 

  9. Bradley, B.W.D., Ansell, B.M.: Fractures in Still's disease, Ann. Rheum. Dis.19:135–142, 1960

    Article  Google Scholar 

  10. Saville, P.D., Kharmosh, O.: Osteoporosis of rheumatoid arthritis: Influence of age, sex and corticosteroids, Arthritis Rheum.10:423–430, 1967

    PubMed  CAS  Google Scholar 

  11. Hahn, T.J., Boisseau, V.C., Avioli, L.V.: Effect of chronic corticosteroid administration on diaphyseal and metaphyseal bone mass, J. Clin. Endocrinol. Metab.39:274–282, 1974

    Article  PubMed  CAS  Google Scholar 

  12. Frost, H.M., Villaneuva, A.R.: Human osteoblastic activity. III. The effect of cortisone on lamellar osteoblastic activity, Henry Ford Hosp. Med. Bull.9:97–99, 1961

    PubMed  CAS  Google Scholar 

  13. Jowsey, J., Riggs, B.L.: Bone formation in hypercortisolism, Acta Endocrinol. (Kbh.)63:21–28, 1970

    CAS  Google Scholar 

  14. Peck, W.A., Brant, J., Miller, I.: Hydrocortisone-induced inhibition of protein synthesis and uridine incorporation in isolated bone cellsin vitro, Proc. Natl. Acad. Sci. U.S.A.57:1599–1606, 1967

    PubMed  CAS  Google Scholar 

  15. Aloia, J.F., Roginsky, M., Ellis, K., Shukla, K., Cohn, S.: Skeletal metabolism and body composition in Cushing's syndrome, J. Clin. Endocrinol. Metab.39:981–985, 1974

    PubMed  CAS  Google Scholar 

  16. Hahn, T.J., Halstead, L.R., Haddad, Jr., J.G.: Serum 25-hydroxyvitamin D concentrations in patients receiving chronic corticosteroid therapy, J. Lab. Clin. Med.90:399–404, 1977

    PubMed  CAS  Google Scholar 

  17. Avioli, L.V., Birge, S.J., Lee, S.W.: Effects of prednisone on vitamin D metabolism in man, J. Clin. Endocrinol. Metab.28:1341–1346, 1968

    PubMed  CAS  Google Scholar 

  18. Klein, R.G., Arnaud, S.B., Gallagher, J.C., DeLuca, H.F., Riggs, B.L.: Intestinal calcium absorption in exogenous hypercortisolism: role of 25-hydroxyvitamin D and corticosteroid dose, J. Clin. Invest.60:253–259, 1977

    PubMed  CAS  Google Scholar 

  19. Chesney, R.W., Hamstra, A.J., Mazeso, R.B., DeLuca, H.F.: Reduction of serum 1,25-dihydroxyvitamin D3 in children receiving glucocorticoids, Lancetii:1123–1125, 1978

    Article  Google Scholar 

  20. Hahn, T.J., Baran, D.T., Halstead, L.R.: Alteration in mineral and vitamin D metabolism produced by subacute prednisone administration in man. Proc. 61st Ann. Meet. Endocr. Soc., June 13–15, 1979, p. 195 (abst.)

  21. Jackson, W.P.U., Lancaster, C.A.: Consideration of the hypercalciuria in sarcoidosis, idiopathic hypercalciuria and that produced by vitamin D. A new suggestion regarding calcium metabolism, J. Clin. Endocrinol. Metab.19:658–680, 1959

    PubMed  CAS  Google Scholar 

  22. Laake, H.: The action of corticosteroids on the renal absorption of calcium, Acta Endocrinol (Kbh.)34:60, 1960

    CAS  Google Scholar 

  23. Bijovet, O.L.M.: Kidney function in calcium and phosphate metabolism. In L.V. Avioli, S.M. Krane, (eds.): Metabolic Bone Disease, Vol. 1, pp. 49–140. Academic Press, New York, 1977

    Google Scholar 

  24. Cannigia, A., Marchetti, M., Gennari, C., Vattimo, A., Nicolis, F.B.: Effects of a new glucocorticoid, oxazacort, on some variables connected with bone metabolism in man: a comparison to prednisone, Int. J. Clin. Pharmacol.15:126–134, 1977

    Google Scholar 

  25. Clinical Investigator's Brochure—DL-458, Clinical Investigation—Medical Department, The Dow Chemical Co., Indianapolis, Indiana, 1978

  26. Hahn, T.J., Hendin, B.A., Scharp, C.R., Haddad, J.G., Jr.: Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults, N. Engl. J. Med.287:900–904, 1972

    Article  PubMed  CAS  Google Scholar 

  27. Tilden, R.L.: New advantageous approach to the direct radioimmunoassay of cortisol, Clin. Chem.23:211–215, 1977

    PubMed  CAS  Google Scholar 

  28. Slatapolsky, E., Cagbar, S., Pennell, J.P., Canterbury, J.M., Reiss, E., Bricker, N.: On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog, J. Clin. Invest.50:492–499, 1971

    Article  Google Scholar 

  29. Haddad, J.G., Jr., Chyu, K.J.: Competitive protein-binding radioassay for 25-hydroxycholecalciferol, J. Clin. Endocrinol. Metab.33:992–995, 1971

    PubMed  CAS  Google Scholar 

  30. Prockop, D.J., Udenfriend, S.: A specific method for the analysis of hydroxyproline in tissues and urine, Anal. Biochem.1:228–237, 1960

    Article  PubMed  CAS  Google Scholar 

  31. Walton, R.J., Bijvoet, O.L.M.: Nomogram for the derivation of renal threshold phosphate concentration, Lancet2:309–310, 1975

    Article  PubMed  CAS  Google Scholar 

  32. Fucik, R.F., Kukreja, S.C., Hargis, G.K.: Effect of glucocorticoids on function of the parathyroid glands in man, J. Clin. Endocrinol. Metab.40:152–155, 1975

    PubMed  CAS  Google Scholar 

  33. Segre, G.V., Niall, H.D., Habener, J.F., Potts, J.T., Jr.: Metabolism of parathyroid hormone: physiologic and clinical significance, Am. J. Med.56:774–778, 1974

    Article  PubMed  CAS  Google Scholar 

  34. Haddad, J.G., Jr., Couranz, S., Avioli, L.V.: Non-dialyzable hydroxyproline as an index of bone collagen formation. J. Clin. Endocrinol. Metab.30:282–287, 1970

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hahn, T.J., Halstead, L.R., Strates, B. et al. Comparison of subacute effects of oxazacort and prednisone on mineral metabolism in man. Calcif Tissue Int 31, 109–115 (1980). https://doi.org/10.1007/BF02407171

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02407171

Key words

Navigation